Skip to content

Feasibility and efficacy of stellate ganglion block for preventing atrial fibrillation after thoraco-laparoscopic esophagectomy for esophageal cancer

Feasibility and efficacy of stellate ganglion block for preventing atrial fibrillation after thoraco-laparoscopic esophagectomy for esophageal cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068592
Enrollment
Unknown
Registered
2023-02-24
Start date
2022-11-23
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative atrial fibrillation

Interventions

Sponsors

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. 20 <= age <= 85 years old; 2. American Society of Anesthesiologists (ASA) grade 1-3; 3. Three-incision McKeown approach for esophageal cancer surgery; 4. Patients voluntarily participated in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. AF, second or third degree atrioventricular block before operation; 2. History of chest surgery; 3. Heart failure; 4. Patients with sleep disorders and sleep apnea syndrome; 5. Abnormal liver and kidney function, electrolyte disorder, thyroid dysfunction and mental disorder; 6. Preoperative use of antiarrhythmic drugs, including ß-blockers, digitalis and calcium channel antagonists; 7. Those who are allergic to local anesthetics; 8. History of neck surgery, scars, anatomical variation, unable to perform stellate ganglion block or block failure; 9. Coagulation disorders or those who are undergoing anticoagulant therapy; 10. Vulnerable groups, including the mentally ill, cognitively impaired, critically ill, minors, pregnant women, illiterate, etc.

Design outcomes

Primary

MeasureTime frame
the incidence of postoperative atrial fibrillation;duration of postoperative atrial fibrillation;

Secondary

MeasureTime frame
vital signs;C reaction protein;inflammatory factor;postoperative pain assessment;

Countries

China

Contacts

Public ContactGang Chen

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine

chengang120@hotmail.com+86 137 5711 8681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026